LnRiLWZpZWxke21hcmdpbi1ib3R0b206MC43NmVtfS50Yi1maWVsZC0tbGVmdHt0ZXh0LWFsaWduOmxlZnR9LnRiLWZpZWxkLS1jZW50ZXJ7dGV4dC1hbGlnbjpjZW50ZXJ9LnRiLWZpZWxkLS1yaWdodHt0ZXh0LWFsaW ...
Agency Seven Stones Product XENICAL Client Roche Therapy Area Nutrition Subscribe to our email news alerts Integrated Care Specialist - North & West Yorkshire Territory Sales Manager - Yorkshire/North ...
A new COVID-19 subvariant, XBB.1.5, is causing concern in the US, where it has been spreading rapidly since December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated ...
Pfizer and Clear Creek Bio have announced a collaboration aiming to advance the discovery and development of novel papain-like protease (PLpro) inhibitors and potentially introduce a new class of oral ...
The companies will supply 105 million doses, which may include adult Omicron-adapted COVID-19 vaccines, subject to FDA authorisation Pfizer and BioNTech have announced a new $3.2bn vaccine supply ...
A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...
A wide range of top-performing healthcare comms agencies, charities and healthcare communicators claimed the honours at last night’s annual Communiqué Awards. The awards, run every year by PMLive’s ...
Kriya is aiming to advance lower cost gene therapies with ‘broader applications’ for disease such as type 1 and type 2 diabetes US-based biotech company Kriya Therapeutics has raised $100m in Series B ...
Healthcare communications network McCann Health has announced the promotion of Adriano Botter (pictured above) to global chief digital officer. Prior to taking on the new role, Botter was digital ...
Moderna announced yesterday that it expects to have between 100 million and 125 million doses of its COVID-19 vaccine available globally in the first quarter of 2021. The company added that 85 million ...
The UK government could approve Pfizer and BioNTech’s COVID-19 vaccine candidate this week, according to a report from The Telegraph. The report, which cited government sources, said that British ...
The US Food and Drug Administration (FDA) has delayed a crucial decision for Bristol Myers Squibb’s CAR-T therapy liso-cel, a key asset gained in the company’s Celgene acquisition. BMS picked up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results